Sjogren's Syndrome Clinical Trials

A listing of Sjogren's Syndrome medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Sall Research Medical Center
Artesia California 90701

A Double-Masked , Randomized, Multi-Center Phase1/2 Study to Evaluate the Efficacy and Safety of the Drug in Subjects with Dry Eye Associated with Sjogren's Syndrome.

View More ▼

Artesia California 90701

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Covina California 91723

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Fullerton California 92835

A clinical trial to evaluate treatments using Abatacept and Placebo for patients with Sjogrens Disease

Los Angeles California 91403

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Rancho Cordova California 95670

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Riverside California 92506

A clinical trial to evaluate treatments using Abatacept and Placebo for patients with Sjogrens Disease

San Francisco California 94143

A clinical trial to evaluate treatments using AMG 557/MEDI5872 and Placebo for patients with Primary Sjögren's Syndrome

Torrance California 90505

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Upland California 91786

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Colorado

Denver Colorado 80230

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Lakewood Colorado 80228

A clinical trial to evaluate treatments using Abatacept and Placebo for patients with Sjogrens Disease

Littleton Colorado 80209

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Connecticut

Trumbull Connecticut 06611

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Florida

View More ▼

Clearwater Florida 33765

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

DeBary Florida 32713

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Fort Lauderdale Florida 33309

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

New Port Richey Florida 34668

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Ormond Beach Florida 32174

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Georgia

Lawrenceville Georgia 30046

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Illinois

Springfield Illinois 62703

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Indiana

Indianapolis Indiana 46260

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Indianapolis Indiana 46290

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Kentucky

The Eye Care Institute
Louisville Kentucky 40206

A Double-Masked, Randomized, Multi-Center Phase I/II Study to Evaluate the Efficacy and Safety of Laripep in Subjects with Dry Eye Associated with Sjögren’s Syndrome

View More ▼

Lexington Kentucky 40504

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Louisville Kentucky 40220

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Louisville Kentucky 40206

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Maryland

The Center for Rheumatology and Bone Research
Wheaton Maryland 20902

Disease Modification in Sjogren's Syndrome Measured by Ultrasound

View More ▼

Baltimore Maryland 21224

A clinical trial seeking patients for a research study for the treatment of Sjögren's Syndrome (SS)

Massachusetts

Worcester Massachusetts 01605

A clinical trial to evaluate treatments using Abatacept and Placebo for patients with Sjogrens Disease

Mississippi

Tupelo Mississippi 38801

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Missouri

Kansas City Missouri 64111

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

St. Louis Missouri 63117

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

St. Louis Missouri 63131

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

New Mexico

View More ▼

Albuquerque New Mexico 87106

A clinical trial seeking patients for a research study for the treatment of Sjögren's Syndrome (SS)

Albuquerque New Mexico 87102

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

New York

Winthrop University Hospital Clinical Trials Center
Mineola New York 11501

A multi-center, randomized, double-blind, placebo controlled, parallel group study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of CFZ533 in patients with primary Sjögren’s syndrome

Winthrop University Hospital Clinical Trials Center
Mineola New York 11501

A multi-center, randomized, double-blind, placebo controlled, parallel group study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy of CFZ533 in patients with primary Sjögren’s syndrome

View More ▼

Great Neck New York 11021

A clinical trial to evaluate treatments using Abatacept and Placebo for patients with Sjogrens Disease

North Carolina

NEW

PMG Research of Salisbury
Salisbury North Carolina 28144

Sjögren’s Syndrome – Comparing 3 Investigational Medications

View More ▼

Charlotte North Carolina 28204

A clinical trial to evaluate treatments using Abatacept and Placebo for patients with Sjogrens Disease

Concord North Carolina 28025

A clinical trial seeking patients for a research study for the treatment of Sjögren's Syndrome (SS)

High Point North Carolina 27262

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Salisbury North Carolina 28144

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome

Ohio

Cleveland Ohio 44115

A clinical trial to evaluate treatments using 0.005% Lacripep, 0.01% Lacripep and Placebo for patients with Primary Sjögren Syndrome or Dry Eye

Oklahoma

Oklahoma City Oklahoma 73103

A clinical trial to evaluate treatments using Abatacept and Placebo for patients with Sjogrens Disease

Pennsylvania

View More ▼

Bethlehem Pennsylvania 18015

A clinical trial to evaluate treatments for patients with Sjogren's Syndrome